威勝信息(688100.SH):鄒啟明、陳君減持計劃時間區間屆滿
格隆匯4月3日丨威勝信息(688100.SH)公佈,公司於2025年4月3日收到鄒啟明先生、陳君先生的吿知函,鄒啟明先生通過大宗交易和集中競價交易方式累計減持公司股份3,728,100股,達到公司目前總股本的0.76%,陳君先生通過集中競價交易方式累計減持公司股份3,999,980股,達到公司目前總股本的0.81%。本次減持計劃實施完成後,鄒啟明先生及陳君先生合計持有公司股份37,854,167股,佔公司總股本的比例為7.70%。兩位股東本次減持計劃時間區間屆滿。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.